<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <previousAccessionNumber>0001104659-22-024316</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001911630</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>3</amendmentNo>
      <securitiesClassTitle>Class A common stock</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>12/31/2024</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001868912</issuerCik>
        <issuerName>Enfusion, Inc.</issuerName>
        <issuerCusip>292812104</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <street1 xmlns="http://www.sec.gov/edgar/common">125 South Clark Street, Suite 750</street1>
          <city xmlns="http://www.sec.gov/edgar/common">Chicago</city>
          <stateOrCountry xmlns="http://www.sec.gov/edgar/common">IL</stateOrCountry>
          <zipCode xmlns="http://www.sec.gov/edgar/common">60603</zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(d)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Malherbe Investments LLC</reportingPersonName>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>6870386</soleVotingPower>
        <sharedVotingPower>0</sharedVotingPower>
        <soleDispositivePower>6870386</soleDispositivePower>
        <sharedDispositivePower>0</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>6870386</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>6.79</classPercent>
      <typeOfReportingPerson>OO</typeOfReportingPerson>
      <comments>Rows 5, 7 and 9 represent 6,870,386 shares of Class A common stock that Malherbe Investments LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC.

Percentage in Row 11 is based on 101,242,457 shares of Class A Common Stock outstanding, which is the sum of (i) 94,372,071 shares of Class A Common Stock outstanding as of October 31, 2024, as reported in the Issuer's Quarterly Report on Form 10-Q filed on November 4, 2024, and (ii) the 6,870,386 shares of Class A Common Stock that Malherbe Investments LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC, which shares have been added to the total shares of Class A Common Stock outstanding pursuant to Rule 13d-3(d)(1)(i)(D) under the Exchange Act.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Stephen Malherbe</reportingPersonName>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>6870386</soleVotingPower>
        <sharedVotingPower>0</sharedVotingPower>
        <soleDispositivePower>6870386</soleDispositivePower>
        <sharedDispositivePower>0</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>6870386</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>6.79</classPercent>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
      <comments>Rows 5, 7 and 9 represent 6,870,386 shares of Class A common stock that Malherbe Investments LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC.
Percentage in Row 11 is based on 101,242,457 shares of Class A Common Stock outstanding, which is the sum of (i) 94,372,071 shares of Class A Common Stock outstanding as of October 31, 2024, as reported in the Issuer's Quarterly Report on Form 10-Q filed on November 4, 2024, and (ii) the 6,870,386 shares of Class A Common Stock that Malherbe Investments LLC has the right to acquire upon the exchange of common units of Enfusion Ltd. LLC, which shares have been added to the total shares of Class A Common Stock outstanding pursuant to Rule 13d-3(d)(1)(i)(D) under the Exchange Act.</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Enfusion, Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>125 South Clark Street, Suite 750, Chicago, Illinois 60603</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>This statement is filed by Malherbe Investments LLC and Stephen Malherbe (together, the "Reporting Persons"). Mr. Malherbe is the sole manager of Malherbe Investments LLC and may be deemed the beneficial owner of the shares held by Malherbe Investments LLC.</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>The principal business office address of the Reporting Persons is 1063 Gallant Court, Wheaton, Illinois 60187.</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Malherbe Investments LLC is a Delaware limited liability company and Stephen Malherbe is a citizen of the United States of America.</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>See responses to Item 9 on each cover page hereto.</amountBeneficiallyOwned>
        <classPercent>See responses to Item 11 on each cover page hereto.</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>See responses to Item 5 on each cover page hereto.</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>See responses to Item 6 on each cover page hereto.</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>See responses to Item 7 on each cover page hereto.</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>See responses to Item 8 on each cover page hereto.</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>Y</notApplicableFlag>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Malherbe Investments LLC</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Stephen Malherbe</signature>
        <title>Sole Manager</title>
        <date>01/31/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Stephen Malherbe</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Stephen Malherbe</signature>
        <title>Stephen Malherbe</title>
        <date>01/31/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
